Stock AEON AEON BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus AEON Biopharma, Inc.

Equities

AEON

US00791X1000

Market Closed - Nyse
Other stock markets
 16:00:00 2024-06-07 EDT 		5-day change 1st Jan Change
1.68 USD +2.44% Intraday chart for AEON Biopharma, Inc. +6.33% -76.67%
05-16 AEON Biopharma, Inc. Announces Termination of Peter Reynolds as Chief Financial Officer, Effective May 17, 2024 CI
05-16 AEON Biopharma, Inc. Announces Executive Changes CI

Evolution of the average Target Price on AEON Biopharma, Inc.

Price target over the last 5 years

History of analyst recommendation changes

fc.oWUNiGGktSFKlXNb0AjvsSOhNQd9dGz4ehT2Li76cMk.-Tdd2AfF5WMYrQZop3yJ4GSUd1MwESvBMiygHWGlKaPDH0_hGZfvEyn3GA~104426da9166ba85b7d1bbf96d65f9dd

Analyst Recommendations on AEON Biopharma, Inc.

HC Wainwright Starts AEON Biopharma at Buy With $18 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.68 USD
Average target price
6 USD
Spread / Average Target
+257.14%
High Price Target
6 USD
Spread / Highest target
+257.14%
Low Price Target
6 USD
Spread / Lowest Target
+257.14%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AEON Biopharma, Inc.

HC Wainwright

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. AEON Stock
  4. Consensus AEON Biopharma, Inc.